677 results found | searching for "pharma"

First Previous 1 2 3 4 5 6 7 8 9 10 Next Last 
  • malexpills
  • Semenax Where To Buy – You will not find Semenax on the shelves of your local pharmacy like GNC, Walmart, Walgreens, or in any online stores like Amazon, eBay. Semenax is only available from their official website. https://readerabode.com/semenax-where-to-buy/ [more]
  • Lizahayden
  • Authorized Pharma Since 2020, buyretinacream has offered healthcare items online at a discounted price with the certainty of quality, dependability, and safety both in the United States and abroad. We are a group of skincare enthusiasts who have joined forces to promote the most common and successful general skincare treatment and to give basic skin needs to people all over the world. [more]
  • jameshebrew
  • The global digital twins market is projected to grow at a CAGR of 30% till 2035, claims Roots Analysis Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain Roots Analysis has announced the addition of “Digital Twins Market, 2022-2035” report to its list of offerings. Since the first application of the digital twin concept for manufacturing in 2002, it has emerged as a crucial component for companies to achieve higher efficiency in their production processes. According to the US-based Digital Twin Consortium, digital twins hold the potential to reduce clinical trial expenditure, turnaround times, staffing expenses and plan medical intervention. Digital twin technology companies are currently engaged in the development of products which are intended for numerous applications, such as asset / process management, personalized treatment and surgical planning. Key Market Insights Over 35 digital twins are presently available in this market space More than 60% of the digital twins offered by industry players are body part twins; these products are primarily intended for asset / process management, personalized treatment and surgical planning. Further, majority of the products that are currently under development are focused on the treatment of indications, such as cardiovascular disorders, metabolic disorders, and neurological disorders. More than 30 players currently claim to be engaged in the digital twin domain Majority of the players engaged in this industry are small firms (11-50 employees, 37%), followed by very large players (10,000+ employees, 22%), large players (501-10,000 employees, 19%), mid-sized players (51-500 employees, 13%) and very small companies (2-10 employees, 9%). Additionally, nearly 70% of the developers are based in Europe, followed by those based in North America (28%). Partnership activity for digital twins witnessed a CAGR of over 15%, in the past three years More than 50% of the partnerships have been signed since January 2020; of these, four partnerships were inked in the year 2022. Technology integration agreements have emerged as the most popular (30%) type of partnership model in the market, followed by technology utilization agreements (23%). Nearly USD 6 billion invested across the globe to advance digital twins focused initiatives A steady increase has been observed in funding activity since 2020, with the maximum number of instances (10) being reported in the year 2021. In fact, more than 90% of the total investment (in terms of the amount invested) was made in the last two years alone (2021- 2022). Of the amount raised in 2022, about USD 4.2 billion was contributed by the IPO of Babylon. Berkus start-up valuation analysis has been performed to evaluate start-ups in this domain The framework enables valuation of start-ups, based on several key success / risk factors . The key factors are assigned monetary values based on the qualities / risks possessed by a particular player. At the end, all valuations were added to calculate the final valuation of the company. Players based in North America are anticipated to capture nearly 30% of the market share by 2035 The overall digital twin market is expected to be primarily driven by the growing interest towards automation and prognostic systems. The estimates in our report suggest that digital twins intended to treat cardiovascular disorders are expected to hold 32% share of the market in 2035. It is interesting to mention that market for digital twins intended to serve pharmaceutical companies and medical device manufacturers, collectively, hold over 60% of the market share in 2035. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/digital-twins-market/request-sample.html Key Questions Answered  Who are the leading players engaged in the development of digital twins for the healthcare domain?  Which type of digital twin is most commonly offered by developers engaged in this market space?  What is the relative competitiveness of different players engaged in the digital twins domain?  What is the likely valuation of start-ups involved in the development of digital twins for the healthcare sector?  What is the present and likely future demand for digital twins in the overall healthcare sector?  What are the anticipated future trends related to digital twins in the healthcare domain?  How is the current and future opportunity likely to be distributed across key market segments? The financial opportunity within the digital twins market in the healthcare domain has been analyzed across the following segments:  Therapeutic Area  Cardiovascular Disorders  Metabolic Disorders  Orthopedic Disorders  Other Disorders  Type of Digital Twin  Process Twins  System Twins  Whole Body Twins  Body Part Twins  Area of Application  Asset / Process Management  Personalized Treatment  Surgical Planning  Diagnosis  Other Applications  End Users  Pharmaceutical Companies  Medical Device Manufacturers  Healthcare Providers  Patients  Other End Users  Key Geographical Regions  North America  Europe  Asia  Latin America  Middle East and North Africa  Rest of the World The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its recent developments (including funding and collaborations) and an informed future outlook.  Babylon  ExactCure  ImmersiveTouch  Navv Systems  ThoughtWire  Unlearn.AI For additional details, please visit https://www.rootsanalysis.com/reports/digital-twins-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Flow Cytometry Service Market, 2022-2035 2. Gene Editing beyond CRISPR Market, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact Information Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com [more]
  • Healthcare_medical
  • Mass Spectrometry Market worth $5.6 billion by 2025 https://bit.ly/3i3da18 The report "Mass Spectrometry Market Size, Growth by Technology [Hybrid (Triple Quadrupole, QTOF, FTMS), Single (Quadrupole, TOF, Ion Trap), Others], Application (Life Science Research, Clinical Diagnostics), Enduser (Pharma-Biotech, Environmental, F&B) - Global Forecasts to 2025", is projected to reach USD 5.6 billion by 2025, at a CAGR of 6.5%. [more]
  • jameshebrew
  • DRIVEN BY THE GROWING DEMAND FOR MEDICAL DEVICES, NOVEL COATINGS PROVIDING UNIQUE FEATURES ARE BEING INTRODUCED IN THE MARKET Over the past 50 years, the medical device industry has seen several notable developments. In fact, the use of biomedical devices, such as medical implants, surgical instruments, and prostheses has increased substantially over the time. Cardioverter defibrillators, prosthetic hips and knees, contact lenses, and cardiac pacemakers are some of the most commonly implanted medical devices, while fixation devices and artificial joints account for about 44% of all medical devices. Despite significant advancements in the design and implantation of medical devices, a number of challenges still persist. Patients, particularly those who are immunocompromised, are at high risk of healthcare-associated infections (HAIs) due to the in-dwelling nature of implanted devices and surgical tools. The risk of infections along with limitations including, implant rejection, osseointegration, degradation and wear, loom over the prosthetic integration. Coatings on biomedical implants can affect this biological interaction between the implant and host, mitigate joint wear, and combine the properties of several materials to enhance device performance as well as reduce the risks associated with invasive medical devices. Medical device coatings also endow properties like lubrication, anti-fouling nature, as well as enhanced durability to the surface of the device. Driven by the surge in demand for various types of medical devices and the need for a wide array of coatings for these devices, the medical device coatings market is anticipated to witness a steady growth in the coming decade. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/medical-device-coatings-market/request-sample.html One of the key challenges associated with in-dwelling medical devices lies in the fact that they are in constant association with the bodily fluids, therefore, interacting with a wide variety of proteins and other biomolecules. This results in denaturization of the biomaterials over time, reducing the overall functional life of the device. As a counter to this problem, surface modification can be utilized. Generally, protein adsorption and biological interactions are significantly impacted by the biomaterial surface modifications, such as modifying the chemistry of polymers, coefficient of friction, domain layout, and shape. Surface modifications, such as plasma spraying, vacuum depositions, etching, and electro-depositions are some of the most frequently procedures to achieve the necessary alterations on medical device surfaces. Various medical devices are associated with the risk of infections, cytotoxicity, thrombogenesis, and immune rejection, which has garnered the attention towards appropriate selection of suitable biomaterials and strategies for modifying the medical devices surface. One of the key developments in the area has been made in creating non-fouling / antibacterial surfaces. A breakthrough in this field has been witnessed in graphene coatings developed to elicit antimicrobial properties. As an alternative to the use of silver nanoparticles earlier, the use of graphene in healthcare applications has a promising future, given the fact that graphene would provide more secure antibacterial properties than metal nanoparticles along with cost efficiency. The detailed competitiveness analysis of various medical device coating providers identified during our research, which are based in North America, Europe, and Asia. Integration of new technologies like advanced laser processing, machine learning, and automation using Artificial Intelligence (AI) also drives the field towards more precise and reproducible coating / surface treatment applications, which can revolutionize the biomedical devices industry. For additional details, please visit https://www.rootsanalysis.com/reports/medical-device-coatings-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com [more]
  • onlinepharmacy1
  • The most popular online pharmacy for over three million patients in Delhi-NCR, Indimedo offers the best prices for prescribed drugs, supplements and more. With customer support available seven days a week, 24 hours a day you are never far away from the pharmacists who are committed to help you find your medications. https://indimedo.com/
  • metrohospitalseo
  • Congratulations on your excellent success and goodluck for your bright future Visit our website http://bit.ly/2HT6oWV to know more about Metro College and its facilities. #MetroNursingCollege #pharmacy #paramedical #ANM #PharmacyCollege #MetroCollege #nursing #nursingcollege #noida #college #TOPPERS #Metro #MetroGroup
  • jameshebrew
  • The clinical trials software market is projected to be growing at a CAGR of 14%, claims Roots Analysis Given the limitations of current clinical trial approaches, including inefficient patient management and data handling, trial sponsors are increasingly opting for innovative technologies and software solutions for conducting clinical trials Roots Analysis has announced the addition of “Clinical Trials Software Market, 2022-2035” report to its list of offerings. Excessive capital expenditure and other complexities associated with the traditional clinical trials has imposed an enormous financial burden on the pharmaceutical industry. Virtual clinical trials software solutions have the potential to induce substantial digital changes in clinical research methodology, resulting in a more patient-centric, cost-effective and easy to manage approach. Key Market Insights Over 70+ companies claim to provide clinical trial software The companies offer clinical trials software with different features like electronic data capture, eCOA/ePRO and eConsent along with decentralized and virtual clinical trials and remote monitoring of the patients. Majority of the players based in North America offer clinical trials software followed by Europe and Asia-Pacific. Further, the market is dominated by the presence of mid-sized players (more than 40%) followed by small and large players. Clinical trial management software is a well-known fact that clinical trials form an integral part of the overall drug development process, enabling innovators to assess safety and efficacy of their drug candidates / devices. These studies account for around 50% of the total time and capital invested in the development process Since 2016, more than 120+ partnerships have been inked by service providers Interestingly, the maximum number of partnership agreements were inked in 2021, majority of these were service agreements (44%), followed by acquisitions/mergers (26%). Further, most of the deals were inked with players based in North America (64%). Over 30 mergers and acquisitions were reported in this domain, during the period 2016-2021 More than 85% of these were instances of acquisitions. Further, majority of the instances involved the companies based in North America and the maximum number of deals were inked in 2019. Over USD 492.8 million has been invested by both private and public investors, since 2016 Majority of the companies (67%) engaged in this domain primarily received funding through venture capital rounds. Further, around 98% of the funding instances were reported by players headquartered in North America. The market is expected to grow at an annual rate close to 14% over the coming decade The opportunity is likely to be well distributed across clinical trials software on the basis of features of software (EDC, eCOA/ePRO and eConsent) and geographies (North America, Europe and Asia-Pacific). By 2035, the clinical trials software market in North America is anticipated to grow at a relatively faster pace (39%), followed by the market in Europe (21%). Clinical trial management system: Driven by the substantial progress in this domain, encouraging virtual clinical trial results, and ongoing technological advancement, the clinical trials software market is anticipated to grow at a commendable pace in the mid to long term. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/clinical-trial-software-market/request-sample.html Key Questions Answered • Who are the leading players engaged in the development of clinical trials software solutions? • Which region(s) will occupy the maximum market share in clinical trials software domain? • Who are the key venture capitalists / strategic investors funding the clinical trials software development initiatives? • Which partnership models are commonly adopted by stakeholders engaged in the development of clinical trials software solutions? • Which factors are likely to influence the evolution of this market? • How is the current and future market opportunity likely to be distributed across key market segments? By 2035, the financial opportunity within the clinical trials software market has been analysed across the following segments: • Features of Software • Electronic Data Capture • eCOA/ePRO • eConsent • Analysis by Geographical Regions • North America • Europe • Asia Pacific The research includes profiles of key players (listed below); each profile features a tabulated overview of company, product portfolio, recent developments, and an informed future outlook. • Advarra • ArisGlobal • AssistRx • Clario • IBM • IQVIA For additional details, please visit https://www.rootsanalysis.com/reports/clinical-trial-software-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Flow Cytometry Service Market, 2022-2035 2. Gene Editing beyond CRISPR Market, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com [more]
  • latestmarketnews
  • The wide range applications of plastic in various industries such as e-commerce, automotive, fast food, pharmaceutical and personal care, where it used for packaging as part of global value chain in the said industries and the sourcing of plastic from the natural oil gas is a challenge that negatively impacts the market in environment of ESG. The other important factor that adversely affects the industry is the degrading aspect of the plastic into the environment. Read More @ https://astra.grandviewresearch.com/plastic-package-industry-esg-outlook About Astra – ESG Solutions by Grand View Research Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm. Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level. For more ESG Thematic reports, please visit @ https://astra.grandviewresearch.com/ [more]
  • Lizahayden
  • HighStreetPharma is one of the best online pharmacies. There are various FDA-approved medications available with express shipment worldwide. HighStreetPharma is a one-stop shop for all of your requirements that has been in business for a decade, delivering inexpensive items to your home with free quick shipping worldwide. See what our clients have to say about our service by reading the 600+ reviews on our website. https://techmorereview.com/companies/highstreetpharma/ [more]
First Previous 1 2 3 4 5 6 7 8 9 10 Next Last